Hogan Lovells advises Shop Apotheke on the listing and admission to trading of €135 million senior unsecured convertible bonds
Led by Frankfurt partner Michael Schlitt, international law firm Hogan Lovells advised Shop Apotheke Europe N.V. on the listing and admission to trading of senior unsecured convertible bonds in the aggregate amount of €135 million. ABN AMRO Bank N.V acted as listing agent for the transaction.
The bonds have been issued in two tranches of €75 and €60 million. The Bonds bear interest of their principal amount of €135 million at a rate of 4.50% per annum and are due in April 2023. The bonds are admitted to trading on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V.
Shop Apotheke will primarily use the net proceeds for its continuous growth strategy, including taking full advantage of the e-script opportunity, a marketplace rollout, enhanced product offering and general corporate purposes
Hogan Lovells previously advised Shop Apotheke on the €50 million capital increase and on the placement of €60 million concurrent tap of existing convertible bonds to fund (2019), issuance of €75 million convertible bonds, and the acquisition of mail-order pharmacy Europa Apotheek (2017) as well as on Shop Apotheke's initial public offering (2016).
Hogan Lovells for Shop Apotheke Europe N.V.
Prof. Dr. Michael Schlitt (Partner, Lead), Dušan Stojković (Senior Associate), Eva-Christina Sommer (Business Lawyer), Sara Šepac (Foreign Associate), Christian Schröder (Research Assistant), Andreas Mildner (Research Assistant), Leon Lindemann (Research Assistant) (all Corporate/Capital Markets).
Victor de Vlaam (Partner), Leonie Huisman (Counsel), Aafke Pronk (Senior Associate), Janelle de Ruiter (Associate) (all Corporate).